Immunomodulation of bone marrow macrophages by GLIS, a proteoglycan fraction from lingzhi or reishi medicinal mushroom Ganoderma lucidium (W.Curt.:Fr.) P. Karst

International Journal of Medicinal Mushrooms

Volumn 13, Issue 5, 2011, Pages 441-448

  Ji, Zhe ^a,b   Tang, Qingjiu ^a   Zhang, Jinsong ^a   Yang, Yan ^a   Liu, Yanfang ^a   Pan, Yingjie ^c  

^a AGRO ENVIRONMENTAL PROTECTION INSTITUTE   (China)

^b Chinese Academy of Sciences   (China)

^c SHANGHAI OCEAN UNIVERSITY   (China)

Author keywords

Bone marrow macro phages; Cytokines; Ganoderma lucidum; Immunoactivation; Medicinal mushrooms

Indexed keywords

GANODERMA LUCIDUM EXTRACT; GANODERMA LUCIDUM IMMUNOMODULATING SUBSTANCE; IMMUNOMODULATING AGENT; INTERLEUKIN 12P35; INTERLEUKIN 12P40; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 6; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BONE MARROW MACROPHAGE; CELL RESPIRATION; CYTOKINE RELEASE; IMMUNOMODULATION; IN VITRO STUDY; MACROPHAGE; MACROPHAGE ACTIVATION; MICROSCOPY; MOUSE; NONHUMAN;

EID: 82355184256     PISSN: 15219437     EISSN: 19404344     Source Type: Journal    
DOI: 10.1615/IntJMedMushr.v13.i5.30     Document Type: Article

References (27)

1. Chan VM, Reznick RK, O'Rourke K, Kitchens JM, Lossing AG, Detsky AS. Meta-analysis of highly selective vagotomy versus truncal vagotomy and pyloroplasty in the surgical treatment of uncomplicated duodenal ulcer. Can J Surg. 1994;37:457-64.
2. Chang ST, Buswell JA. Medicinal mushrooms-a prominent source of nutriceuticals for the 21st century. Curr Top Nutraceut Res. 2003;1:257-80.
3. Paterson RR. Ganoderma-a therapeutic fungal biofactory. Phytochemistry. 2006;67:1985-2001.
4. Akihisa T, Nakamura Y, Tagata M, Tokuda H, Yasukawa K, Uchiyama E, Suzuki T, Kimura Y. Anti-inflammatory and anti-tumor-promoting effects of triterpene acids and sterols from the fungus Ganoderma lucidum. Chem Biodivers. 2007;4:224-31.
5. Berger A, Rein D, Kratky E, Monnard I, Hajjaj H, Meirim I, Piguet-Welsch C, Hauser J, Mace K, Niederberger P. Cholesterol-lowering properties of Ganoderma lucidum in vitro, ex vivo, and in hamsters and minipigs. Lipids Health Dis. 2004;3:2.
6. Lin ZB, Zhang HN. Anti-tumor and immunoregulatory activities of Ganoderma lucidum and its possible mechanisms. Acta Pharmacol Sin. 2004;25:1387-95.
7. Sliva D. Ganoderma lucidum (Reishi) in cancer treatment. Integr Cancer Ther. 2003;2:358-64.
8. Shi YL, James AE, Benzie IF, Buswell JA. Mushroomderived preparations in the prevention of H2O2-induced oxidative damage to cellular DNA. Teratog Carcinog Mutagen. 2002;22:103-11.
9. Tasaka K, Akagi M, Miyoshi K, Mio M, Makino T. Antiallergic constituents in the culture medium of Ganoderma lucidum. (I). Inhibitory effect of oleic acid on histamine release. Agents Actions. 1988;23:153-6.
10. Fujita R, Liu J, Shimizu K, Konishi F, Noda K, Kumamoto S, Ueda C, Tajiri H, Kaneko S, Suimi Y, Kondo R. Anti-androgenic activities of Ganoderma lucidum. J Ethnopharmacol. 2005;102:107-12.
11. Li YQ, Wang SF. Anti-hepatitis B activities of ganoderic acid from Ganoderma lucidum. Biotechnol Lett. 2006;28:837-41.
12. Zhang J, Tang Q, Zimmerman-Kordmann M, Reutter W, Fan H. Activation of B lymphocytes by GLIS, a bioactive proteoglycan from Ganoderma lucidum. Life Sci. 2002;71:623-38.
13. Stanley ER. Murine bone marrow-derived macrophages. Methods Mol Biol. 1997;75:301-4
14. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem. 1982;126:131-8.
15. Tadros H, Chretien M, Mbikay M. The testicular germcell protease PC4 is also expressed in macrophage-like cells of the ovary. J Reprod Immunol. 2001;49:133-52.
16. Kim E, Kang BY, Kim TS. Inhibition of interleukin-12 production in mouse macrophages by hydroquinone, a reactive metabolite of benzene, via suppression of nuclear factor-kappaB binding activity. Immunol Lett. 2005;99:24-9.
17. Chen X, Hu ZP, Yang XX, Huang M, Gao Y, Tang W, Chan SY, Dai X, Ye J, Ho PC, Duan W, Yang HY, Zhu YZ, Zhou SF. Monitoring of immune responses to a herbal immuno-modulator in patients with advanced colorectal cancer. Int Immunopharmacol. 2006;6:499-508.
18. Wang SY, Hsu ML, Hsu HC, Tzeng CH, Lee SS, Shiao MS, Ho CK. The anti-tumor effect of Ganoderma lucidum is mediated by cytokines released from activated macrophages and T lymphocytes. Int J Cancer. 1997;70:699-705.
19. Yun TK. Update from Asia. Asian studies on cancer chemoprevention. Ann N Y Acad Sci. 1999;889:157-92.
20. Berovic M, Habijanic J, Zore I, Wraber B, Hodzar D, Boh B, Pohleven F. Submerged cultivation of Ganoderma lucidum biomass and immunostimulatory effects of fungal polysaccharides. J Biotechnol. 2003;103:77-86.
21. Lin ZB. Cellular and molecular mechanisms of immunomodulation by Ganoderma lucidum. J Pharmacol Sci. 2005;99:144-53.
22. Hahn H, Kaufmann SH. The role of cell-mediated immunity in bacterial infections. Rev Infect Dis. 1981;3:1221-50.
23. Fidler IJ, Kleinerman ES. Therapy of cancer metastasis by systemic activation of macrophages: from the bench to the clinic. Res Immunol. 1993;144:284-7; discussion 294-8.
24. Zirk NM, Hashmi SF, Ziegler HK. The polysaccharide portion of lipopolysaccharide regulates antigen-specific T-cell activation via effects on macrophage-mediated antigen processing. Infect Immun. 1999;67:319-26.
25. Stuehr DJ, Marletta MA. Synthesis of nitrite and nitrate in murine macrophage cell lines. Cancer Res. 1987;47:5590-4.
26. Adachi Y, Okazaki M, Ohno N, Yadomae T. Enhancement of cytokine production by macrophages stimulated with (1→3)-beta-D-glucan, grifolan (GRN), isolated from Grifola frondosa. Biol Pharm Bull. 1994;17:1554-60.
27. Baehner RL, Nathan DG. Leukocyte oxidase: defective activity in chronic granulomatous disease. Science. 1967;155:835-6.